Società Avricore Health Inc Toronto S.E.
Azioni
APH
CA92143R2046
Prodotti farmaceutici
Attività
Vendite per attività
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Health Data and Point-of-care Technologies
100,0
%
| 0 | 100,0 % | 2 | 100,0 % | +1.339,95% |
Vendite per regione
CAD in Milioni | 2021 | Peso | 2022 | Peso | Delta |
---|---|---|---|---|---|
Canada
100,0
%
| 0 | 100,0 % | 2 | 100,0 % | +1.339,95% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Hector Bremner
CEO | Chief Executive Officer | - | 01/01/19 |
Kiki Smith
DFI | Director of Finance/CFO | - | 06/08/19 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/12/20 |
Mark Kunzli
PRN | Corporate Officer/Principal | - | - |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
David Hall
CHM | Chairman | 71 | 20/01/16 |
Robert Sindelar
BRD | Director/Board Member | 71 | 27/03/18 |
Christine Hrudka
BRD | Director/Board Member | - | 21/06/23 |
Rodger Seccombe
CTO | Chief Tech/Sci/R&D Officer | - | 08/12/20 |
Alan Arnstein
BRD | Director/Board Member | 56 | 20/04/17 |
Hector Bremner
CEO | Chief Executive Officer | - | 01/01/19 |
Thomas Teahen
BRD | Director/Board Member | - | 21/06/23 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 1 | 99 869 664 | 90 194 935 ( 90,31 %) | 0 | 90,31 % |
Coordinate società
Avricore Health, Inc.
789 West Pender Street Suite 1120
V6C 1H2, Vancouver
+
http://www.avricorehealth.comSettore
Variaz. 1 gen. | Capi. | |
---|---|---|
+26,08% | 662 Mrd | |
+21,85% | 546 Mrd | |
-4,77% | 359 Mrd | |
+16,97% | 323 Mrd | |
+5,69% | 290 Mrd | |
+13,68% | 234 Mrd | |
+3,65% | 198 Mrd | |
-11,12% | 194 Mrd | |
-3,40% | 157 Mrd |